Serum miR-146a as a diagnostic and predictive biomarker for osteoporosis and bisphosphonate treatment efficacy

Serum miR-146a shows promise as a diagnostic and predictive biomarker for osteoporosis and the efficacy of bisphosphonate therapy. It plays a role in suppressing osteoclast differentiation, and bisphosphonates may exert their therapeutic effects in part by upregulating miR-146a. These findings suggest that targeting miR-146a could be a novel strategy for osteoporosis management.